Family-based Association Study of Killer Cell Immunoglobulin-Like Receptor Genes with Leukemia

1. http://www.allelefrequencies.net/diseases/Search in Google Scholar

2. Mandelboim O, Reyburn H, Vales-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med, 1996, 184, 913-922.10.1084/jem.184.3.91321927879064351Search in Google Scholar

3. Collona M, Samaridis S. Cloning of immunoglobulin-super-family members associated with HLA-C and HLA-B recognition by human natural killer cells. Science, 1995, 268: 405-408.10.1126/science.77165437716543Search in Google Scholar

4. Foley B, De Santis D, Van Beelen E, et al. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1:implications for patient and donor suitability for haploidentical stem cell rans-plantations. Blood, 2008, 112, 435-443.10.1182/blood-2008-01-13290218385451Search in Google Scholar

5. Gumperz J, Litwin V, Philips J et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med, 1995; 181, 1133-1144.10.1084/jem.181.3.113321919337532677Search in Google Scholar

6. Hansasuta P, Dong T, Thananchi H, et al. Recognition of HLAA3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol, 2004, 34, 1673-1679.10.1002/eji.20042508915162437Search in Google Scholar

7. Biassoni R, Pessino A, Malaspina A, et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol, 1997, 27, 3095-3099.10.1002/eji.18302712039464792Search in Google Scholar

8. Stewart C, Laugier-Anfossi F, Vely F, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA, 2005, 102, 13224-13229.10.1073/pnas.0503594102120158416141329Search in Google Scholar

9. Single R, Martin MP, Gao X, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet, 2007, 39, 1114-1119.10.1038/ng207717694058Search in Google Scholar

10. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med, 2007, 204, 3027-3036.10.1084/jem.20070695211852418025129Search in Google Scholar

11. Khakoo SI, Carrington M. KIR and disease: a model system or system of models. Immunol Rev, 2006, 214, 186-201.10.1111/j.1600-065X.2006.00459.x17100885Search in Google Scholar

12. Karabon L, Jedynak A, Giebel S, et al. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease. Tissue Antigens, 2011, 78, 129-138.10.1111/j.1399-0039.2011.01721.x21726204Search in Google Scholar

13. Besson C, Roetync S, Williams F, et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin lymphoma in a familial study. PLoS ONE, 2007, 2(5), e406.10.1371/journal.pone.0000406185323617476328Search in Google Scholar

14. Shahsavar F, Tajik N, Entezami K, et al. KIR2DS3 is associated with protection against acute myeloid leukemia. Iran J Immunol, 2010, 7, 8-17.Search in Google Scholar

15. Verheyden S, Demanet C. Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia, 2006, 20, 1437-1438.10.1038/sj.leu.240427916761016Search in Google Scholar

16. Pamuk GE, Tozkir H, Uyanik MS, et al. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course. Leuk Lymphoma, 2015, 56(10), 2902-7.10.3109/10428194.2015.101436125699652Search in Google Scholar

17. Sullivan EM, Jeha S, Kang G, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res, 2014, 20(23), 5986-94.10.1158/1078-0432.CCR-14-0479425274525281696Search in Google Scholar

18. Misra MK, Prakash S, Moulik NR, et al. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. Hum Immunol, 2016, 77(1), 41-6.10.1016/j.humimm.2015.10.00926472014Search in Google Scholar

19. Sugioka DK, Gonçalves CE, Bicalho MD. KIR repertory in patients with hematopoietic diseases and healthy family members. BMC Hematology, 2016, 16, 25.10.1186/s12878-016-0064-6504129327708784Search in Google Scholar

20. https://www.ebi.ac.uk/ipd/kir/Search in Google Scholar

21. Varbanova V, Mihaylova A, Naumova E. Olerup SSP KIR HLA ligand typing Kit. A new opportunity for KIR ligand assignment in clinical settings. C R Acad Bulg Sci, 2010, 63(5), 713-722.Search in Google Scholar

22. Gonzalez-Galarza F, Christmas S, Middleton D, Jones A. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Research, 2011, 39, D913-D919.10.1093/nar/gkq1128301371021062830Search in Google Scholar

23. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet, 1993, 52: 506-516.Search in Google Scholar

24. Wall J, Pritchard J. Haplotypes blocks and linkage disequilibrium in the human genome. Nat Rev Genet, 2003, 4, 587-597.10.1038/nrg112312897771Search in Google Scholar

25. Knapp M. The transmission/disequilibrium test and parental-genotype reconstruction: the reconstruction-combined transmission/disequilibrium test. Am J Hum Genet, 1999, 64, 861-870.10.1086/302285137780410053021Search in Google Scholar

26. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet, 1998, 62, 450-458.10.1086/30171413768909463321Search in Google Scholar

27. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype–phenotype associations. Eur J Hum Genet, 2001, 9, 301-306.10.1038/sj.ejhg.520062511313775Search in Google Scholar

28. Faure M, Longo E. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol, 2002, 168, 6208-14.10.4049/jimmunol.168.12.620812055234Search in Google Scholar

29. Kikuchi-Maki A, Yusa S, Catina T, Cambpbell K. KIR2DL4 is an IL-2 regulated NK cells receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol, 2003, 171, 3415-3425.10.4049/jimmunol.171.7.341514500636Search in Google Scholar

30. Hsu K, Chida S, Geraghty D and Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunological Reviews, 2002, 190, 40-52.10.1034/j.1600-065X.2002.19004.x12493005Search in Google Scholar